Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample
Authors:
- Mark OlfsonMOMark Olfson
- Steven C. MarcusSMSteven C. Marcus
- Benjamin G. DrussBDBenjamin G. Druss
Open Access
- 1 January 2008
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 65 (1) , 94-101
Abstract
In several contexts, Food and Drug Administration (FDA) warnings of serious adverse drug events have been followed by reductions in use of the targeted medications.1-3 Over the past 4 years, the FDA and other regulatory agencies have issued various warnings concerning the risk of suicidal thoughts and actions associated with antidepressant medications, especially in the treatment of children and adolescents. Although these warnings have been widely reported by the public and professional press, their effects on the prescription of antidepressant medications remain a subject of debate.4,5 A recent analysis of Verispan data reported that the number of youth antidepressant prescriptions per month significantly increased from April 2002 to February 2004, then tended to decline until July 2004, before stabilizing over the next 8 months.5 These trends suggest that media attention to antidepressant safety may have influenced antidepressant prescribing in youth. However, no information was provided in this study regarding the effects of individual FDA advisories on specific antidepressant medication use over time or on their effects on the rate of antidepressant use in specific demographic and clinical populations.Keywords
This publication has 33 references indexed in Scilit:
- Impact of Publicity Concerning Pediatric Suicidality Data on Physician Practice Patterns in the United StatesArchives of General Psychiatry, 2007
- Suicidality in Pediatric Patients Treated With Antidepressant DrugsArchives of General Psychiatry, 2006
- After the black box warning: dramatic changes in ED use of droperidolThe American Journal of Emergency Medicine, 2005
- Overview of Diagnosis and Drug Treatments of Anxiety DisordersCNS Spectrums, 2005
- Antidepressants and Pediatric Depression — The Risk of Doing NothingNew England Journal of Medicine, 2004
- COUNSELING VERSUS ANTIDEPRESSANT THERAPY FOR THE TREATMENT OF MILD TO MODERATE DEPRESSION IN PRIMARY CAREInternational Journal of Technology Assessment in Health Care, 2003
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy and Therapeutics, 2002
- Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of ?dear doctor? lettersPharmacoepidemiology and Drug Safety, 2001
- Psychiatric Diagnosis in Child and Adolescent SuicideArchives of General Psychiatry, 1996
- Suicidal Ideation Related to Fluoxetine TreatmentNew England Journal of Medicine, 1991